Altria's stock defies earnings dip as investors reposition ahead of dividend
Altria's latest financial results have sparked mixed reactions among investors. The company's earnings fell just below expectations, while its stock continues to climb. With a dividend payout on the horizon, major shareholders are reshuffling their positions.
Altria reported earnings per share of $1.30, slightly missing analyst predictions. Revenue also dipped by 0.5% compared to the same period last year. Despite this, the stock has risen by roughly 15% since January, reaching a relative strength index (RSI) of 76.9—a level some analysts consider overbought.
Since early 2024, Altria's market capitalisation has grown from about $75 billion to $90 billion, with shares climbing from $40 to $55. This represents a 20% increase, though competitors like Philip Morris International saw stronger gains (+35%), while British American Tobacco lagged (+10%). Imperial Brands performed similarly to Altria, up by around 18%.
Investor activity has been notably active. Mainstay Capital Management, Wilmington Savings Fund Society, and Swiss Life Asset Management all cut their stakes. Meanwhile, Stillwater Wealth Management Group opened a new position worth $1.52 million. These shifts come ahead of the ex-dividend date on March 25, with the payout set for April 30.
The company's quarterly dividend offers a yield of about 6.5%, but its payout ratio exceeds 103%, raising questions about long-term sustainability. Beyond financials, Altria faces broader industry pressures, including stricter nicotine pouch regulations in Spain and a rise in illicit tobacco trade across global markets.
Altria's next key date for shareholders is March 25, when the stock will trade ex-dividend. The payout, due on April 30, remains a focal point for investors weighing the company's financial health. With regulatory challenges intensifying and stock performance diverging from competitors, the coming months will likely bring further adjustments in shareholder positions.
